Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Protalix BioTherapeutics (PLX) Tax Rate (2023 - 2025)

Historic Tax Rate for Protalix BioTherapeutics (PLX) over the last 3 years, with Q3 2025 value amounting to 7.82%.

  • Protalix BioTherapeutics' Tax Rate fell 236100.0% to 7.82% in Q3 2025 from the same period last year, while for Sep 2025 it was 15.9%, marking a year-over-year increase of 160900.0%. This contributed to the annual value of 29.42% for FY2024, which is 96400.0% down from last year.
  • Latest data reveals that Protalix BioTherapeutics reported Tax Rate of 7.82% as of Q3 2025, which was down 236100.0% from 75.19% recorded in Q2 2025.
  • Over the past 5 years, Protalix BioTherapeutics' Tax Rate peaked at 75.19% during Q2 2025, and registered a low of 7.82% during Q3 2025.
  • Over the past 3 years, Protalix BioTherapeutics' median Tax Rate value was 3.04% (recorded in 2024), while the average stood at 10.22%.
  • The largest annual percentage gain for Protalix BioTherapeutics' Tax Rate in the last 5 years was 721500bps (2025), contrasted with its biggest fall of -236100bps (2025).
  • Over the past 3 years, Protalix BioTherapeutics' Tax Rate (Quarter) stood at 5.94% in 2023, then skyrocketed by 89bps to 11.24% in 2024, then plummeted by -170bps to 7.82% in 2025.
  • Its Tax Rate stands at 7.82% for Q3 2025, versus 75.19% for Q2 2025 and 3.03% for Q1 2025.